Picture of Labcorp Holdings logo

LH Labcorp Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Annual cashflow statement for Labcorp Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,3801,281419747878
Depreciation
Deferred Taxes
Non-Cash Items325627771369510
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-264-603-362-154-526
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities3,1101,9561,3281,5861,641
Capital Expenditures-460-482-454-490-435
Purchase of Fixed Assets
Other Investing Cash Flow Items-424-1,170-718-877-760
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-885-1,652-1,172-1,367-1,194
Financing Cash Flow Items-74-77.61,440217179
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,066-1,322-59.3780-1,457
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash152-1,043107982-986